David O. Zamora
University of Texas Health Science Center at San Antonio
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David O. Zamora.
Investigative Ophthalmology & Visual Science | 2010
David O. Zamora; Jeffrey W. Kiel
PURPOSE To determine the episcleral venous pressure (EVP) responses to nitroprusside (NP) and L-NAME. METHODS In anesthetized rabbits (n = 36), arterial pressure and IOP were measured by direct cannulation, and carotid blood flow and heart rate were measured with an ultrasound flowmeter and cardiotachometer. EVP was measured in two groups with a servonull system. Group 1 (n = 13) was given NP (50 microL, 10 mg/mL). Group 2 (n = 10) was given L-NAME (100 microL, 10 mg/mL) followed by NP (50 microL, 10 mg/mL). In group 3 (n = 13), fluorophotometric aqueous flow was measured before and after NP (100 microL, 10 mg/mL). RESULTS Systemic parameters were unaffected by treatment in all groups. In group 1, NP increased EVP from 9.1 +/- 0.6 to 11.6 +/- 0.8 mm Hg (P < 0.01) and IOP from 18.7 +/- 1.4 to 23.9 +/- 1.6 mm Hg (P < 0.01). In group 2, L-NAME lowered EVP from 11.5 +/- 1.2 to 8.8 +/- 1.0 mm Hg (P < 0.01) and subsequent NP increased EVP to 13.9 +/- 1.7 mm Hg (P < 0.01 versus L-NAME and baseline). L-NAME decreased IOP from 20.8 +/- 1.7 to 16.7 +/- 1.8 mm Hg (P < 0.01), and then it increased to 20.7 +/- 1.3 mm Hg after NP (P < 0.01 versus L-NAME and P > 0.05 versus baseline). In group 3, NP increased IOP from 16.6 +/- 0.7 to 20.0 +/- 0.9 mm Hg (P < 0.01) but did not alter aqueous flow (2.65 +/- 0.3 vs. 3.0 +/- 0.3 microL/min, P > 0.05). CONCLUSIONS Because a topical NO donor raises EVP and a topical NO synthase inhibitor lowers EVP, the authors conclude that EVP is modulated by NO.
Investigative Ophthalmology & Visual Science | 2009
David O. Zamora; Jeffrey W. Kiel
PURPOSE To determine the effect of proparacaine-induced topical anesthesia on episcleral venous pressure (EVP). METHODS In anesthetized rabbits (n = 11), EVP was measured with a servonull micropressure system, with glass pipettes with 2- to 3-microm tips used to cannulate episcleral veins. Additional measurements included arterial, intraocular, and orbital venous pressures obtained by direct cannulation, to assess the ocular pressure gradients, and carotid blood flow and heart rate, to verify preparation stability. The protocol entailed 5 to 10 minutes of stable baseline recording followed by topical application of proparacaine (0.5%, 10 microL) with continued measurements for another 5 to 15 minutes. RESULTS Baseline EVP without topical anesthesia was 12.3 +/- 1.1 mm Hg. EVP decreased significantly to 8.7 +/- 0.9 mm Hg within minutes after application of proparacaine. A small decrease also occurred in intraocular pressure. All other measured variables were unchanged. CONCLUSIONS These results suggest that the episcleral circulation is under tonic neural control and that either an upstream resistance site is under tonic vasodilatory control or a downstream site is under vasoconstrictor control.
Investigative Ophthalmology & Visual Science | 2003
Matthew D. Silverman; David O. Zamora; Yuzhen Pan; Paul V. Texeira; Seung Hee Baek; Stephen R. Planck; James T. Rosenbaum
Investigative Ophthalmology & Visual Science | 2007
Justine R. Smith; Dongseok Choi; Timothy J. Chipps; Yuzhen Pan; David O. Zamora; Michael H. Davies; Bobby Babra; Michael R. Powers; Stephen R. Planck; James T. Rosenbaum
Investigative Ophthalmology & Visual Science | 2005
David O. Zamora; Michael H. Davies; Stephen R. Planck; James T. Rosenbaum; Michael R. Powers
Investigative Ophthalmology & Visual Science | 2004
Justine R. Smith; Daniel T. Franc; Nicola S. Carter; David O. Zamora; Stephen R. Planck; James T. Rosenbaum
Investigative Ophthalmology & Visual Science | 2001
Matthew D. Silverman; David O. Zamora; Yuzhen Pan; Paul V. Texeira; Stephen R. Planck; James T. Rosenbaum
Journal of Translational Medicine | 2017
Lauren E. Cornell; Whitney Greene; Rachel O. Haich; Lee C. Mangum; Gerardo R. Garcia; Charles H. Guymon; Kevin S. Akers; Jennifer Landry; Jennifer S. McDaniel; Gina L. Griffith; Elaine D. Por; David Rios; David O. Zamora; Brian Lund; Alexandra M. Forbes; Joel D. Newton; Timothy M. Mok; Josue Garcia-Marcano; Andres Penagos-Nino; Jeffrey D. Keesee; Xiaowu Wu; Harvey Harper; Bin Liu; Aaron M. Lewis; Martin G. Schwacha; Andrew P. Cap; Daniel N. Darlington; Allison E. Tempel; David Silliman; Rose Grimm
Investigative Ophthalmology & Visual Science | 2015
Barbara Wirostko; Gina L. Griffith; David O. Zamora; MaryJane Rafii; Anthony J. Johnson; Hee-Kyoung Lee
Investigative Ophthalmology & Visual Science | 2017
Lauren Cornell; Jennifer S. McDaniel; Brian Lund; David O. Zamora
Collaboration
Dive into the David O. Zamora's collaboration.
University of Texas Health Science Center at San Antonio
View shared research outputs